Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Intervention and Measurement of Pharmacokinetics of Linezolid in Tuberculosis Meningitis: a Pharmacokinetics and Safety/Tolerability Study

NCT03537495 is registered in ClinicalTrials.gov with Universitas Padjadjaran as lead sponsor.

NCT NCT03537495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03537495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Intervention and Measurement of Pharmacokinetics of Linezolid in Tuberculosis Meningitis: a Pharmacokinetics and Safety/Tolerability Study
Lead sponsor
Universitas Padjadjaran
Phase
Phase 2
Overall status
Completed
Start date
June 21, 2021
Completion date
July 20, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

linezolid, tuberculosis, meningeal